Helicobacter pylori treatment practices in the Asia-Pacific region
Effective treatment of gastric cancer-bacterial infections begins with understanding differing clinical methods
2025-03-18
(Press-News.org)
Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high in the Asia-Pacific region. Approximately 90% of cases are linked to H. pylori bacterial infections, but preemptive eradication can reduce the incidence of gastric cancer by 30-40%.
However, the increase in antimicrobial drug-resistant bacteria used in eradication therapy is a major issue. In addition, while secondary prevention through endoscopic examinations is also important for the early detection of gastric cancer, it is not clear to what extent Asia-Pacific practitioners recognize its importance.
An international research group led by Dr. Koji Otani and Professor Yasuhiro Fujiwara of the Osaka Metropolitan University Graduate School of Medicine conducted an online survey of clinicians in the Asia-Pacific region to investigate treatment policies for H. pylori. Based on the responses from each country regarding the methods of diagnosis, antibacterial drug dosages, treatment periods, and the need for secondary prevention, the research team confirmed that there is a growing consensus of the importance of primary and secondary prevention against H. pylori.
“At present, differences in the incidence of antimicrobial resistance and gastric cancer between regions, medical resources, and policies are affecting the formation of uniform standards for gastric cancer prevention,” stated Dr. Otani. “In the future, it will be important to establish treatment guidelines for H. pylori infections that are appropriate for each region, taking into consideration the actual situation of antimicrobial resistance and gastric cancer in each Asian country.”
The findings were published in the Journal of Gastroenterology and Hepatology.
###
About OMU
Established in Osaka as one of the largest public universities in Japan, Osaka Metropolitan University is committed to shaping the future of society through “Convergence of Knowledge” and the promotion of world-class research. For more research news, visit https://www.omu.ac.jp/en/ and follow us on social media: X, Facebook, Instagram, LinkedIn.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-03-18
UNDER EMBARGO UNTIL 00:01 AM UK TIME ON TUESDAY 18 MARCH 2025
Almost one in ten people (9.1%) in England think they could have Long Covid but aren’t sure, according to a new analysis of NHS England survey data by the University of Southampton.
Researchers also found that 4.8% of people reported having Long Covid, with higher rates among people living in deprived areas, people with particular ethnic backgrounds, parents or carers, and those with another long-term condition.
The findings are published today [18 March] ...
2025-03-18
Researchers at Heriot-Watt University have made a ground-breaking discovery paving the way for a transformative era in photonic technology.
For decades, scientists have theorised the possibility of manipulating the optical properties of light by adding a new dimension—time. This once-elusive concept has now become a reality thanks to nanophotonics experts from the School of Engineering and Physical Sciences in Edinburgh, Scotland.
The team’s breakthrough emerged from experiments with nanomaterials known as transparent conducting oxides (TCOs) - a special ...
2025-03-17
(MEMPHIS, Tenn. – March 17, 2025) As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus’s threat to human health. The virus has been found in dairy cows’ milk and has infected farm workers, prompting scientists at St. Jude Children’s Research Hospital to study potential treatments. Results showed that in a preclinical model, two FDA–approved flu antivirals generally did not successfully treat severe H5N1 infections. Additionally, the researchers found that the route of infection, whether through ...
2025-03-17
Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the Center of Vaccine Development and Global Health, UMB. Currently, there are no approved vaccines against the Lassa virus. The clinical study is a dose-ranging study that will assess the safety and immunogenicity of the candidate vaccine for both the rabies virus and LASV.
The experimental vaccine is based on an attenuated and killed rabies virus vaccine similar to current rabies vaccines and has an additional ...
2025-03-17
Outpatient primary care clinics at Hebrew SeniorLife’s Orchard Cove and NewBridge on the Charles communities have been recognized by the Institute for Healthcare Improvement (IHI) as Age-Friendly Health Systems — Committed to Care Excellence.
“I want to express my gratitude to the team at Hebrew SeniorLife for your dedication to age-friendly care,” said Leslie Pelton, MPA, Vice President, Institute for Healthcare Improvement (IHI). “Age-Friendly Health Systems and IHI celebrate your recognition as an Age-Friendly ...
2025-03-17
For decades, atomic clocks have been the pinnacle of precision timekeeping, enabling GPS navigation, cutting-edge physics research, and tests of fundamental theories. But researchers at JILA, led by JILA and NIST Fellow and University of Colorado Boulder physics professor Jun Ye, in collaboration with the Technical University of Vienna, are pushing beyond atomic transitions to something potentially even more stable: a nuclear clock. This clock could revolutionize timekeeping by using a uniquely low-energy transition within the nucleus of a thorium-229 atom. This transition is less sensitive to environmental disturbances than modern atomic clocks and has been proposed for tests of fundamental ...
2025-03-17
FOR IMMEDIATE RELEASE
Monday, March 17, 2025
Contact:
Jillian McKoy, jpmckoy@bu.edu
Michael Saunders, msaunder@bu.edu
##
As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people who could benefit from medications have access to the drugs that the US Food and Drug Administration has approved to treat AUD. Yet, for individuals who have alcohol use disorder and are covered by Medicaid, accessing these medications is difficult; past research indicates that only about 1 in 20 Medicaid enrollees with alcohol use disorder receive these ...
2025-03-17
Mount Sinai Researchers Find Specific Therapy That Teaches Patients to Tolerate Stomach and Body Discomfort Improved Functional Brain Deficits Linked to Visceral Disgust That Can Cause Food Avoidance in Adolescent Females with Anorexia Nervosa and other Low-Weight Eating Disorders
Corresponding Author: Kurt P. Schulz, PhD, Associate Professor, Center of Excellence in Eating and Weight Disorders, Icahn School of Medicine at Mount Sinai, New York, and other co-authors
Bottom Line: A trial of interoceptive exposure - a therapy that teaches patients how to tolerate stomach and body discomfort in order to reduce restrictive eating - improved functional deficits in a brain region ...
2025-03-17
Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf ...
2025-03-17
18th March 2025, Sydney: In an Australian first, a team of scientists led by Australian Museum and UNSW Sydney palaeontologist, Dr Matthew McCurry, have described a new species of 15-million-year-old fossilised freshwater fish, Ferruaspis brocksi, that shows preserved stomach contents as well as the pattern of colouration. The research is published today in The Journal of Vertebrate Palaeontology (DOI - 10.1080/02724634.2024.2445684)
Named after Professor Jochen J. Brocks from the Australian National University, who discovered several of the fossilised species at the Australian Museum’s, McGraths Flat fossil site near Gulgong, NSW, Ferruaspis brocksi is the first ...
LAST 30 PRESS RELEASES:
[Press-News.org] Helicobacter pylori treatment practices in the Asia-Pacific region
Effective treatment of gastric cancer-bacterial infections begins with understanding differing clinical methods
